Trevena, Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Statements of Redeemable Convertible Preferred Stock and Stockholders' Equity (Deficit)

Statements of Redeemable Convertible Preferred Stock and Stockholders' Equity (Deficit) (USD $)	Series A convertible preferred stock Common Stock	Series A convertible preferred stock Additional Paid-in Capital	Series A convertible preferred stock	Series B convertible preferred stock Common Stock	Series B convertible preferred stock Additional Paid-in Capital	Series B convertible preferred stock	Series B 1 convertible preferred stock Common Stock	Series B 1 convertible preferred stock Additional Paid-in Capital	Series B 1 convertible preferred stock	Series C convertible preferred stock Common Stock	Series C convertible preferred stock Additional Paid-in Capital	Series C convertible preferred stock	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Accumulated Other Comprehensive Loss	Total
Balance at Dec. 31, 2012													$ 682	$ 19,718	$ (59,017,415)		$ (58,997,015)us-gaap_StockholdersEquity
Balance at Dec. 31, 2012			25,004,123			30,770,194			3,183,517								58,957,834
Balance (in shares) at Dec. 31, 2012													682,494
Balance (in shares) at Dec. 31, 2012			25,074,999			30,800,000			4,200,000
Increase (Decrease) in Temporary Equity
Issuance of convertible preferred stock, net of issuance costs												59,918,917					59,918,917
Issuance of convertible preferred stock, net of issuance costs (in shares)												36,764,704
Exercise of Series B-1 preferred stock warrants									1,351,677								1,351,677
Exercise of Series B-1 preferred stock warrants (in shares)									550,000
Accretion of Series A, Series B/B-1 and Series C convertible preferred stock to its redemption value			20,250			8,506			287,885			17,069					333,710
Increase (Decrease) in Stockholders' Equity
Stock-based compensation expense														927,996			927,996
Exercise of stock options													276	83,279			83,555
Exercise of stock options (in shares)													275,262
Accretion of Series A, Series B/B-1 and Series C convertible preferred stock to its redemption value														(333,710)			(333,710)
Net loss															(23,251,435)		(23,251,435)us-gaap_NetIncomeLoss
Conversion of convertible preferred stock to common stock upon initial public offering (in shares)																	15,708,013
Balance at Dec. 31, 2013													958	697,283	(82,268,850)		(81,570,609)us-gaap_StockholdersEquity
Balance at Dec. 31, 2013			25,024,373			30,778,700			4,823,079			59,935,986					120,562,138
Balance (in shares) at Dec. 31, 2013													957,756				957,756us-gaap_CommonStockSharesOutstanding
Balance (in shares) at Dec. 31, 2013			25,074,999			30,800,000			4,750,000			36,764,704					97,389,703
Increase (Decrease) in Temporary Equity
Accretion of Series A, Series B/B-1 and Series C convertible preferred stock to its redemption value			1,688			709			23,990			2,134					(28,521)
Conversion of Series A convertible preferred stock to common stock upon initial public offering			(25,026,061)														(25,026,061)
Conversion of Series A convertible preferred stock to common stock upon initial public offering (in shares)			(25,074,999)
Conversion of Series B convertible preferred stock to common stock upon initial public offering				4,968	30,774,441	(30,779,409)											30,779,409
Conversion of Series B convertible preferred stock to common stock upon initial public offering (in shares)				4,967,741		(30,800,000)
Conversion of Series B-1 convertible preferred stock to common stock upon initial public offering									(4,847,069)								(4,847,069)
Conversion of Series B-1 convertible preferred stock to common stock upon initial public offering (in shares)									(4,750,000)
Conversion of Series C convertible preferred stock to common stock upon initial public offering												(59,938,120)					(59,938,120)
Conversion of Series C convertible preferred stock to common stock upon initial public offering (in shares)												(36,764,704)
Increase (Decrease) in Stockholders' Equity
Stock-based compensation expense														2,383,399			2,383,399
Exercise of stock options													186	111,592			111,778
Exercise of stock options (in shares)													186,682
Accretion of Series A, Series B/B-1 and Series C convertible preferred stock to its redemption value														(28,521)			(28,521)
Change in unrealized investment losses																(18,782)	(18,782)
Net loss															(49,700,875)		(49,700,875)us-gaap_NetIncomeLoss
Conversion of convertible preferred stock to common stock upon initial public offering	4,044	25,022,017	(25,026,061)			(30,779,409)	766	4,846,303	4,847,069	5,930	59,932,190	(59,938,120)
Conversion of convertible preferred stock to common stock upon initial public offering (in shares)	4,044,354						766,129			5,929,789
Net conversion of preferred stock warrants common stock upon initial public offering													20	(20)
Net conversion of preferred stock warrants common stock upon initial public offering (in shares)													20,273
Reclassification of convertible preferred stock warrant liability														145,256			145,256
Issuance of common stock warrants														1,000			1,000us-gaap_ProceedsFromIssuanceOfWarrants
Issuance of common stock, net of issuance costs													22,369	107,267,954			107,290,323
Issuance of common stock (in shares)													22,368,449
Balance at Dec. 31, 2014													$ 39,241	$ 231,152,894	$ (131,969,725)	$ (18,782)	$ 99,203,628us-gaap_StockholdersEquity
Balance (in shares) at Dec. 31, 2014													39,241,173				39,241,173us-gaap_CommonStockSharesOutstanding
Balance (in shares) at Dec. 31, 2014			0			0			0			0